Health Trials

Non-Small Cell Lung Cancer、EGFR Sensitive Mutation

1

Review clinical trials related to Non-Small Cell Lung Cancer、EGFR Sensitive Mutation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation

To evaluate the safety and tolerance of MCLA-129 combined with Befotertinib in patients with advanced non-small cell lung cancer with EGFR-sensitive mutations.

Participants needed: 172
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Betta Pharmaceuticals Co., Ltd.Updated: Aug 29, 2023Locations: 3
Eligibility criteria

Age from 18 to 75 years. [+9]

Use of certain investigational drug or antineoplastic agent within 14 days or 5... [+23]

Read more